Patentability/Prior-art Search and Written Assessment (Software)

SKU: PT-02

A formal written patentability assessment for internal use, founders, advisors, or initial investor conversations.

$950.00

Quantity

Buy Now

Engagement type: Flat Fee

Best for A formal written patentability assessment for internal use, founders, advisors, or initial investor conversations.

What’s included

Review of client disclosure and any client-supplied prior art.
Attorney prior-art look across patent and selected non-patent literature.
Written opinion analyzing novelty (§102) and non-obviousness (§103) against the closest references identified.

What’s NOT included

Government, third-party, foreign-associate, translation, courier, and vendor fees.
Continued prosecution, additional office actions, or post-allowance work beyond what is expressly itemized.
Litigation, contested proceedings (IPR/PGR/PTAB, oppositions, cancellations), or appeal work.
Work on additional applications, jurisdictions, classes, or marks not listed in the engagement letter.
Investor-grade independent third-party search.
Freedom-to-operate (infringement) analysis — see FTO services.

Client responsibilities

Assumptions

Standard complexity for the service category.
One primary applicant or business entity; one primary jurisdiction unless otherwise stated.
One round of substantive client revisions included.
No material adverse facts (e.g., prior public disclosure, intervening prior art) discovered after engagement.
Search scope is what is reasonably accessible to attorney; not an exhaustive worldwide search.

Scope-change triggers

Material change in scope, claims, embodiments, classes, marks, or jurisdictions.
Adversarial action by a third party (opposition, cancellation, declaratory action).
Expedited / emergency turnaround required to meet a statutory or self-imposed deadline.
After-discovered prior art, prior use, or undisclosed prior filings.

Deliverables Written patentability opinion (typically 6–10 pages) with cited references.

Typical timing Typically 1-2 weeks from complete disclosure.

A streamlined provisional offering listed on the firm's website at a promotional rate.

Sophisticated inventors who will supply a substantially complete written disclosure and want attorney review and filing.

Reviewing the IP position around a specific biomarker, panel, or signature before clinical, commercial, or licensing decisions.

Patentability work in molecular biology, diagnostics, therapeutics, and related life-science areas, where literature volume drives effort.

Decisions about whether and how to file continuations, continuation-in-part, or divisional applications to extend or refine claim coverage.

Streamlined design patent filings for single-design products.

You filed. That does not mean you are covered.